107323-82-0

Basic information

• Product Name: Magnesium, bromo[(4-chlorophenyl)methyl]-
• Synonyms: .p-Chlor-benzylmagnesiumbromid;.4-Chlor-benzylmagnesium-bromid;p-chlorobenzylmagnesium bromide
• CAS NO: 107323-82-0
• Molecular Formula: C7H6BrClMg
• Molecular Weight: 229.787
• Mol File: 107323-82-0.mol

Chemical Properties

• CAS DataBase Reference: Magnesium, bromo[(4-chlorophenyl)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Magnesium, bromo[(4-chlorophenyl)methyl]-(107323-82-0)
• EPA Substance Registry System: Magnesium, bromo[(4-chlorophenyl)methyl]-(107323-82-0)

Safety Data

• Hazardous Substances Data: 107323-82-0(Hazardous Substances Data)

Upstream product

• 622-95-7 4-chlorobenzyl bromide 

Downstream Products

• 7504-29-2 1-(2-chlorophenyl)-2-(4-chlorophenyl)ethanone 
• 22584-81-2 (4-chloro-benzyl)-dihydroxy-borane 
• 167886-53-5 3,4'-dichloro-deoxybenzoin 
• 52578-11-7 2-(4-chlorophenyl)-1-(4-methoxyphenyl)ethanone 
• 6332-83-8 2-(4-chlorophenyl)-1-phenylethanone 
• 5468-97-3 1-(4-chlorophenyl)-2-methyl-2-propanol 
• 51490-05-2 1,2-bis(4-chlorophenyl)ethanone 
• 22711-23-5 4-chlorobenzil 
• 56594-96-8 2-(4-chlorophenyl)-1-cyclopropylethan-1-one 
• 142728-02-7 9-(4-Chloro-benzyl)-3,6,10,10-tetramethyl-9,10-dihydro-phenanthren-9-ol 
• 71899-33-7 1-hydroxy-1-(p-chlorobenzyl)-2,2-dimethylacenaphthene 
• 100199-08-4 (1S,2S)-1-(4-Chloro-benzyl)-2-[1,2,4]triazol-1-yl-cycloheptanol 
• 107680-30-8 (2S,3R)-1,3-Bis-(4-chloro-phenyl)-2-(4-fluoro-phenyl)-4-[1,2,4]triazol-1-yl-butane-2,3-diol 
• 107680-31-9 (2S,3R)-1-(4-Chloro-phenyl)-3-(2,4-dichloro-phenyl)-2-phenyl-4-[1,2,4]triazol-1-yl-butane-2,3-diol 

Relevant articles and documents

Dynamic kinetic asymmetric cross-benzoin additions of β-stereogenic α-keto esters

The dynamic kinetic resolution of β-halo α-keto esters via an asymmetric cross-benzoin reaction is described. A chiral N-heterocyclic carbene catalyzes the umpolung addition of aldehydes to racemic α-keto esters. The resulting fully substituted β-halo glycolic ester products are obtained with high levels of enantio- and diastereocontrol. The high chemoselectivity observed is a result of greater electrophilicity of the α-keto ester toward the Breslow intermediate. The reaction products are shown to undergo highly diastereoselective substrate-controlled reduction to give highly functionalized stereotriads.

Heterocyclic derivative and pharmaceutical composition comprising the same

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X3 and/or P2X2/3 receptor antagonistic effect comprising a compoun

NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X3 and/or P2X2/3 receptor antagonistic effect comprising a compoun